Starved to death: Can dietary methionine combat cancer?
The organic compounds that come together to form proteins are called . The human body uses amino acids as sources of energy for functions such as homeostasis, growth, and repair. While the body can produce some amino acids (known as nonessential), others are strictly obtained through food (known as essential).
The essential amino acid , or Met, is critical for genetic regulation, protein production, cell metabolism and DNA repair. Unlike noncancerous cells, most cancer cells cannot recycle Met efficiently; instead, cancer cells rely on a continuous supply of methionine from external sources for growth. This vulnerability is known as Met dependence, or Met stress sensitivity.
Researchers do not know much yet about the mechanisms behind Met dependence in cancer; however, a published in the Journal of Lipid Research has brought us closer to understanding the role of Met dependence in cancer cell lipid metabolism. of the University of California, Irvine, and collaborators at the and used Met-dependent and Met-independent breast cancer cell lines to characterize the lipid changes that occur in response to Met-dependent stress.

In the cell, diverse make up the cellular membrane and aid in signaling and transport; lipids are also important for nutrient and energy storage. While lipid metabolism is studied widely in relationship to heart disease, researchers know little about lipid metabolism in cancer.
“In cancers, specifically in breast cancer, there has always been a connection to lipid metabolism,” Kaiser said. “We are very interested in understanding how these changes in lipids can affect cancer cells and how they can translate into feasible drug targets.”
Kaiser and colleagues fed cancer cells Met-deficient media to induce stress and then used high-performance liquid chromatography, genetic analysis, and cell microscopy to characterize the changes that occurred in lipids. The researchers found that lipid remodeling and abundance are affected directly by Met-deprivation stress in cancer cells.
Compared to the Met-independent cells (which do not require externally provided Met), the researchers saw an accumulation of lipid droplets, a decrease in lipid synthesis, and a global decrease in all lipid types (except triglycerides; these underwent remodeling), in the Met-dependent cancer cells (which require a continuous external supply of Met). These changes suggest Met stress may affect the , or ER, an organelle in the cell responsible for many metabolic processes, including lipid synthesis.
“A lot of proteins are folded in the ER,” Kaiser said. “This can lead to a stress response because protein folding becomes impacted in the ER as a consequence of the changes occurring to the lipids.”
These findings support a previous in which reduced dietary Met helped shrink tumors in rats when used in conjunction with radiation or chemotherapeutics.
Kaiser and his colleagues seek to understand the molecular mechanisms involved in cancer Met dependence. His lab is also interested in the relationship between Met dependence and cell cycle regulation. These studies could increase knowledge of the unique metabolic needs of cancer cells and lead to better therapies.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ¾ÅÓÎÌåÓý paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent ¾ÅÓÎÌåÓý paper.